Biotechnology

New NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia offers a comprehensive look at the latest expert recommendations for treating a common, highly-curable childhood and adolescent cancer Credit: NCCN

Researchers at the University of California, San Diego (UCSD), the University of Texas at Austin, and Maynooth University in Dublin, Ireland, have uncovered an active role for glycans—sugar molecules that can coat proteins—in the...

“ Commercial Seeds (Conventional, Biotechnology) Market Forecast 2020-2026 The Global Commercial Seeds (Conventional, Biotechnology) Market research report provides and in-depth analysis on industry- and economy-wide database for business management that could potentially offer development and profitability...

Sep 23 2020 OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV. OXGENE’s new TESSA™ technology addresses industry-wide challenges associated...

The Nuclear Threat Initiative (NTI) convened a meeting of more than 40 experts worldwide to address the need for better oversight of biotechnology research. Biotechnology research is essential for reducing pandemic threats and supporting global...

Funding will move novel cancer technologies from the lab to the clinic Credit: BioCanRx OTTAWA, ON (Tuesday, September 22, 2020, 8 a.m. ET) – BioCanRx, Canada’s Immunotherapy Network,...

Affecting millions of people worldwide, osteoarthritis (OA) is the most common form of arthritis. It occurs when the protective cartilage that cushions the ends of your bones wears down over time. X-rays of the...

Interview conducted by Emily Henderson, B.Sc.Sep 22 2020 Thought LeadersStepan NersisyanResearcher in Biology and BiotechnologyHSE University In this interview, News-Medical speaks to Stepan Nersisyan about his research efforts during the COVID-19 pandemic, and his discovery...

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood. About 15% of leukemias in...

Credit: The University of Texas at Austin. An international team of researchers have found a way to refine and reliably produce an unpredictable and hard-to-control material that...